Loading
Latest filing published 21 Feb 2008 for BRADLEY PHARMACEUTICALS INC, €101k.
No signal scores available.
Ralph N. Landau discloses dealings in Bradley Pharmaceuticals Inc to SEC (Form 4). Activity is concentrated on a single trading day, 21 February 2008, with 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 21 February 2008: a transaction of €272k, in Bradley Pharmaceuticals Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations